Reuters/ABC News reports on research published in the Journal of the American Medical Association that examined the misuse of two blood thinners - Lovenox and Integrilin - in "about 20 percent of kidney dialysis patients who undergo a procedure to open a blocked artery [who] are given the wrong blood clot medicine, increasing the chances of significant bleeding, researchers said Tuesday. They said the findings suggest many doctors in the United States ignore warnings on drug labels, often putting patients at risk of serious harm or death." The two drugs "are not recommended for use in kidney dialysis patients" (Wilson, 12/8). U.S. News and World Report/HealthDay: "According to [study author Dr.
Fighting Prostate Cancer With Speed And Accuracy: RapidArc reg; Radiotherapy Available At The Delaware Valley Urology Cancer Treatment Center
Former New Jersey Assemblyman Francis Bodine was surprised and delighted when his radiotherapy treatment sessions for prostate cancer went from about 20 minutes each day to less than five. Midway through his course of treatment, doctors at the Delaware Valley Urology Cancer Center acquired the region's first RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: VAR), making it possible for them to deliver advanced intensity-modulated radiotherapy (IMRT) treatments two to eight times faster than was previously possible At the time Bodine's treatments began, his doctor was using what was then the state-of-the-art for IMRT--an advanced form of treatment that shapes the beam to match the shape of the tumor and minimizes exposure of surrounding healthy tissues.
The effectiveness of PSA (prostate-specific antigen) screening on reducing prostate cancer mortality has been given a boost with new data from the European Randomized Study of Screening for Prostate Cancer (ERSPC). This shows the true impact to be far higher than previously reported up to 31%. Preliminary ERSPC findings showed that screening reduced prostate cancer deaths by 20%. This latest ERSPC analysis corrects for non-attendance and contamination to assess the effectiveness of PSA testing in those men actually screened From 1992, the ERSPC study randomized 162, 000 men, aged 55 to 69, in seven European countries to either a screening arm or a control group.
Surgeons who successfully performed kidney transplants after removing small cancerous and benign masses from the donated organs, have published their results in the December issue of the urology journal BJUI. The technique, carried out by US surgeons at the University of Maryland School of Medicine in Baltimore, could offer a vital lifeline to patients with end-stage renal disease as well as increasing the supply of viable organs. "Transplanting a living donor kidney which has been affected by a renal mass is controversial and considered a high risk" says co-author Dr Michael W Phelan. "However the ongoing shortage of organs from deceased donors, and the high risk of dying while waiting for a transplant, prompted five donors and recipients to push ahead with surgery after the small masses were found in the donor kidneys.
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the approval of the first over-the-counter (OTC) medicine to treat the symptoms of benign prostatic hyperplasia (BPH) in men, to be available through pharmacies without a prescription. An estimated one-in-four men over the age of 40 suffer from BPH, the progressive enlargement of the prostate gland. Symptoms include urinary hesitancy, weak stream, and frequent urination, including at night. Tamsulosin capsules will be available to buy under the brand name Flomax Relief, for short-term use in men aged 45 to 75 following a consultation with a pharmacist. Patients will need to obtain a GP diagnosis prior to longer-term use and annual check-ups are recommended thereafter.
Ice Water Testing Reveals Hypersensitivity In Adult Rats That Experienced Neonatal Bladder Inflammation
UroToday.com - Animal Models Show Long-Term Effects of Neonatal Inflammation, implications for painful bladder syndrome/interstitial cystitis The majority of female patients with BPS report pain during urodynamics when ice-cold saline in instilled after the routine testing. This is not the case with patients with detrusor overactivity or normal controls.(1) Dr. Alan Randich and co-workers from Birmingham, Alabama sought to look at an animal model with female rat pups to determine whether rats that underwent neonatal bladder inflammation would show enhanced electromyogram (EMG) responses during ice water testing as adults. Intravesical zymosan was used to cause bladder inflammation in the neonates.